141 related articles for article (PubMed ID: 36047328)
21. [Clinical aspects and therapy of skin malignancies in the head and neck area].
Ermanni D; Grossenbacher R
HNO; 1992 Sep; 40(9):331-3. PubMed ID: 1399710
[TBL] [Abstract][Full Text] [Related]
22. Basal cell carcinoma of the head and neck: identification of predictors of recurrence.
Bumpous JM; Padhya TA; Barnett SN
Ear Nose Throat J; 2000 Mar; 79(3):200-2, 204. PubMed ID: 10743767
[TBL] [Abstract][Full Text] [Related]
23. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Staged Excision With Permanent Section Margin Control for Cutaneous Head and Neck Melanoma.
Moyer JS; Rudy S; Boonstra PS; Kraft C; Chinn SB; Baker SR; Schwartz JL; Bichakjian CK; Fullen D; Durham AB; Lowe L; Johnson TM
JAMA Dermatol; 2017 Mar; 153(3):282-288. PubMed ID: 28002553
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Pigmented Basal Cell Carcinoma with 3 mm Surgical Margin in Asians.
Lin SH; Cheng YW; Yang YC; Ho JC; Lee CH
Biomed Res Int; 2016; 2016():7682917. PubMed ID: 27652267
[TBL] [Abstract][Full Text] [Related]
26. [The margin of safety and depth of excision in surgical treatment of basalioma. Use of 3-dimensional histologic study of 2,016 tumors].
Breuninger H; Schippert W; Black B; Rassner G
Hautarzt; 1989 Nov; 40(11):693-700. PubMed ID: 2606668
[TBL] [Abstract][Full Text] [Related]
27. [The evaluation of tumor histopathology, location, characteristic, size and thickness of nonmelanoma skin cancers of the head and neck].
Eskiizmir G; Ozgür E; Temiz P; Gençoğlan G; Ermertcan AT
Kulak Burun Bogaz Ihtis Derg; 2012; 22(2):91-8. PubMed ID: 22548266
[TBL] [Abstract][Full Text] [Related]
28. Recurrence rate of basal cell carcinoma in patients submitted to skin flaps or grafts.
Kondo RN; Gon ADS; Pontello Junior R
An Bras Dermatol; 2019; 94(4):442-445. PubMed ID: 31644617
[TBL] [Abstract][Full Text] [Related]
29. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
Spraul CW; Ahr WM; Lang GK
Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of histopathological margin and other recurrence parameters in basal cell carcinoma: A retrospective analysis of 8821 lesions.
Yildizdal S; Kucukguven A; Calis M; Vargel I
J Plast Reconstr Aesthet Surg; 2022 Sep; 75(9):3390-3397. PubMed ID: 35902332
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of surgical treatment of nonmelanoma skin cancer of the head and neck in Greece.
Seretis K; Thomaidis V; Karpouzis A; Tamiolakis D; Tsamis I
Dermatol Surg; 2010; 36(1):15-22. PubMed ID: 19912277
[TBL] [Abstract][Full Text] [Related]
32. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
33. Demographics of basal cell carcinoma and its surgical management.
Afridi RA; Ahmed E; Khan SA; Ali A
J Ayub Med Coll Abbottabad; 2012; 24(3-4):141-3. PubMed ID: 24669636
[TBL] [Abstract][Full Text] [Related]
34. Recurrence rates of primary nonmelanoma skin cancers treated by surgical excision compared to electrodesiccation-curettage in a private dermatological practice.
Werlinger KD; Upton G; Moore AY
Dermatol Surg; 2002 Dec; 28(12):1138-42; discussion 1142. PubMed ID: 12472494
[TBL] [Abstract][Full Text] [Related]
35. [The recurrence of facial basal cell carcinoma in patients treated at the Head and Neck Surgery Ward and Laryngological Oncology Clinic of the Greater Poland Cancer Centre in the years 2007-2010].
Pazdrowski J; Dańczak-Pazdrowska A; Golusiński P; Szybiak B; Silny W; Golusiński W
Otolaryngol Pol; 2012; 66(3):185-90. PubMed ID: 22748679
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas.
Kimyai-Asadi A; Alam M; Goldberg LH; Peterson SR; Silapunt S; Jih MH
J Am Acad Dermatol; 2005 Sep; 53(3):464-8. PubMed ID: 16112354
[TBL] [Abstract][Full Text] [Related]
37. Basal Cell Carcinoma in the Southern Health Area of Tenerife. Key Clinical and Pathological Factors and Margin Status After Excision.
Loizate Sarrionandia I; de-la-Rosa Fernández E; González Rodríguez J; Hernández Hernández MN; Pelegrina ME; Castro Tarruella MV; Suárez Hernández J; Fernández-de-Misa Cabrera R
Actas Dermosifiliogr; 2023 Sep; 114(8):674-679. PubMed ID: 37100344
[TBL] [Abstract][Full Text] [Related]
38. Recurrent basal cell carcinoma after incomplete resection.
Robinson JK; Fisher SG
Arch Dermatol; 2000 Nov; 136(11):1318-24. PubMed ID: 11074691
[TBL] [Abstract][Full Text] [Related]
39. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision.
Silverman MK; Kopf AW; Bart RS; Grin CM; Levenstein MS
J Dermatol Surg Oncol; 1992 Jun; 18(6):471-6. PubMed ID: 1592998
[TBL] [Abstract][Full Text] [Related]
40. 5 years review of periocular basal cell carcinoma and proposed follow-up protocol.
Ho SF; Brown L; Bamford M; Sampath R; Burns J
Eye (Lond); 2013 Jan; 27(1):78-83. PubMed ID: 23154501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
